CYP7A1 polymorphism influences the LDL cholesterol-lowering response to atorvastatin.

Jiang, X-Y

CYP7A1 polymorphism influences the LDL cholesterol-lowering response to atorvastatin. [electronic resource] - Journal of clinical pharmacy and therapeutics Dec 2012 - 719-23 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1365-2710

10.1111/j.1365-2710.2012.01372.x doi


ATP Binding Cassette Transporter, Subfamily G, Member 8
ATP-Binding Cassette Transporters--genetics
Aged
Atorvastatin
China
Cholesterol 7-alpha-Hydroxylase--genetics
Cholesterol, LDL--blood
Cytochrome P-450 CYP3A--genetics
Female
Genetic Variation
Genotype
Heptanoic Acids--pharmacology
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology
Hypercholesterolemia--drug therapy
Male
Middle Aged
Polymorphism, Single Nucleotide
Pyrroles--pharmacology